Back to Search
Start Over
Antagonist mineralokortikoidnih receptora eplerenon u suvremenom liječenju kardiovaskularnih bolesnika.
- Source :
-
Cardiologia Croatica . Oct2019, Vol. 14 Issue 9/10, p263-269. 7p. - Publication Year :
- 2019
-
Abstract
- Aldosterone and eplerenone are mineralocorticoid receptor antagonists with one of the main roles in the treatment of heart failure, as demonstrated by large randomized controlled trials. Effects on patient outcomes are the result of blocking the renin-angiotensin-aldosterone system, which improves cardiac remodeling. Besides heart failure, mineralocorticoid receptor antagonists are used in treatment of patients with resistant arterial hypertension. This review focuses on the pharmacokinetics, pharmacodynamics, clinical effects, and safety profile of eplerenone. [ABSTRACT FROM AUTHOR]
Details
- Language :
- Croatian
- ISSN :
- 1848543X
- Volume :
- 14
- Issue :
- 9/10
- Database :
- Academic Search Index
- Journal :
- Cardiologia Croatica
- Publication Type :
- Academic Journal
- Accession number :
- 139464667
- Full Text :
- https://doi.org/10.15836/ccar2019.263